Evidence map›Paper›PMID 30564185›Full record

ArticleFrontiers in neurology2018

Next Generation Molecular Diagnosis of Hereditary Spastic Paraplegias: An Italian Cross-Sectional Study.

Angelica D'Amore, Alessandra Tessa, Carlo Casali, Maria Teresa Dotti, Alessandro Filla, Gabriella Silvestri, Antonella Antenora, Guja Astrea, Melissa Barghigiani, Roberta Battini and 43 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 5 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 5 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Selective dorsal rhizotomy for spasticity of genetic etiology.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2020
    Pooled it
  5. Frontiers in neuroscience · 2019
    Pooled it
  6. Article
  7. Article
  8. Article
  9. Hereditary spastic paraplegia: from decades of therapy to future innovations.Therapeutic advances in neurological disorders · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Hereditary spastic paraparesis type 18 (SPG18): new ERLIN2 variants in a series of Italian patients, shedding light upon genetic and phenotypic variability.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

53 authors at 20 institutions in 3 countries.

Angelica D'AmoreMolecular Medicine, Pisa, Italy.
Alessandra TessaMolecular Medicine, Pisa, Italy.
Carlo CasaliDepartment of Medical and Surgical Sciences and Biotechnologies, University of Rome Sapienza, Latina, Italy.
Maria Teresa DottiDepartment of Medicine, Surgery and Neurosciences, Medical School, University of Siena, Siena, Italy.
Alessandro FillaDepartment of Neurosciences, Reproductive and Odontostomatologic Sciences, Federico II University, Naples, Italy.
Gabriella SilvestriIRCCS Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.
Antonella AntenoraDepartment of Neurosciences, Reproductive and Odontostomatologic Sciences, Federico II University, Naples, Italy.
Guja AstreaMolecular Medicine, Pisa, Italy.
Melissa BarghigianiMolecular Medicine, Pisa, Italy.
Roberta BattiniMolecular Medicine, Pisa, Italy.
Carla BattistiDepartment of Medicine, Surgery and Neurosciences, Medical School, University of Siena, Siena, Italy.
Irene BrunoDepartment of Pediatrics, Institute for Maternal and Child Health-IRCCS Burlo Garofolo, Trieste, Italy.
Cristina CeredaGenomic and Post-Genomic Center, IRCCS Mondino Foundation, Pavia, Italy.
Clemente DatoSecond Division of Neurology, Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Luigi Vanvitelli, Naples, Italy.
Giuseppe Di IorioSecond Division of Neurology, Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Luigi Vanvitelli, Naples, Italy.
Vincenzo DonadioIRCCS Istituto delle Scienze Neurologiche di Bologna-UOC Clinica Neurologica, Bologna, Italy.
Monica FelicoriIstituto delle Scienze Neurologiche di Bologna-UOC Neuropsichiatria Infantile, Bologna, Italy.
Nicola FiniDepartment of Neurosciences, Sant'Agostino-Estense Hospital, Azienda Ospedaliero Universitaria di Modena, Modena, Italy.
Chiara FiorilloPediatric Neurology and Neuromuscular Disorders, University of Genoa and Istituto Giannina Gaslini, Genova, Italy.
Salvatore GalloneNeurology I, Department of Neuroscience and Mental Health, AOU Città della Salute e della Scienza, Turin, Italy.
Federica GemignaniDepartment of Biology, University of Pisa, Pisa, Italy.
Gian Luigi GigliNeurology Clinic, Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine, Italy.
Claudio GrazianoMedical Genetics Unit, Sant'Orsola-Malpighi University Hospital, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Renzo GuerriniPediatric Neurology Unit, Children's Hospital A. Meyer, University of Firenze, Florence, Italy.
Fiorella GurrieriInstitute of Genomic Medicine, Catholic University of the Sacred Heart, Rome, Italy.
Ariana KariminejadClinical Genetics, Kariminejad-Najmabadi Pathology & Genetics Research Center, Tehran, Iran.
Maria LietoDepartment of Neurosciences, Reproductive and Odontostomatologic Sciences, Federico II University, Naples, Italy.
Charles Marques LourenḈoNeurogenetics Division, Clinics Hospital of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
Alessandro MalandriniDepartment of Medicine, Surgery and Neurosciences, Medical School, University of Siena, Siena, Italy.
Paola MandichDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Section of Medical Genetics, University of Genoa, Genoa, Italy.
Christian MarcotulliDepartment of Medical and Surgical Sciences and Biotechnologies, University of Rome Sapienza, Latina, Italy.
Francesco MariPediatric Neurology Unit, Children's Hospital A. Meyer, University of Firenze, Florence, Italy.
Luca MassacesiDepartment of Neurosciences Drugs and Child Health, University of Florence, Florence, Italy.
Maria A B MeloneSecond Division of Neurology, Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Luigi Vanvitelli, Naples, Italy.
Andrea MignarriDepartment of Medicine, Surgery and Neurosciences, Medical School, University of Siena, Siena, Italy.
Roberta MiloneChild Neuropsychiatry, ULSS 7 Pedemontana, Vicenza, Italy.
Olimpia MusumeciDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Elena PegoraroDepartment of Neurosciences, University of Padua, Padua, Italy.
Alessia PernaIRCCS Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.
Antonio PetrucciNeurology Department, San Camillo Hospital, Rome, Italy.
Antonella PiniIstituto delle Scienze Neurologiche di Bologna-UOC Neuropsichiatria Infantile, Bologna, Italy.
Francesca PochieroMetabolic and Muscular Unit, Neuroscience Department, Meyer Children's Hospital, Florence, Italy.
Maria Roser PonsFirst Department of Pediatrics, Aghia Sophia Children's Hospital, University of Athens, Athens, Greece.
Ivana RiccaMolecular Medicine, Pisa, Italy.
Salvatore RossiIRCCS Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.
Marco SeriMedical Genetics Unit, Sant'Orsola-Malpighi University Hospital, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Franco StanzialClinical Genetics Service and South Tyrol Coordination Center for Rare Diseases, Department of Pediatrics, Regional Hospital of Bolzano, Bolzano, Italy.
Francesca TinelliMolecular Medicine, Pisa, Italy.
Antonio ToscanoDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Mariarosaria ValenteNeurology Clinic, Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine, Italy.
Antonio FedericoDepartment of Medicine, Surgery and Neurosciences, Medical School, University of Siena, Siena, Italy.
Anna RubegniMolecular Medicine, Pisa, Italy.
Filippo Maria SantorelliMolecular Medicine, Pisa, Italy.
European School of Molecular Medicine · ITUniversity of Siena · ITFederico II University Hospital · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITIstituto delle Scienze Neurologiche di Bologna · ITMeyer Children's Hospital · ITUniversity of Campania "Luigi Vanvitelli" · ITOspedale Santa Maria · ITSapienza University of Rome · ITUniversity of Messina · ITUniversity of Pisa · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITAzienda Unita' Sanitaria Locale Di Modena · ITCenter for Genomic Science · ITIRCCS Materno Infantile Burlo Garofolo · ITIRCCS San Camillo Hospital · ITIstituto Giannina Gaslini · ITNational and Kapodistrian University of Athens · GROspedale di Bolzano · ITPoliclinico S.Orsola-Malpighi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary spastic paraplegia (HSP) refers to a group of genetically heterogeneous neurodegenerative motor neuron disorders characterized by progressive age-dependent loss of corticospinal motor tract function, lower limb spasticity, and weakness. Recent clinical use of next generation sequencing (NGS) methodologies suggests that they facilitate the diagnostic approach to HSP, but the power of NGS as a first-tier diagnostic procedure is unclear. The larger-than-expected genetic heterogeneity-there are over 80 potential disease-associated genes-and frequent overlap with other clinical conditions affecting the motor system make a molecular diagnosis in HSP cumbersome and time consuming. In a single-center, cross-sectional study, spanning 4 years, 239 subjects with a clinical diagnosis of HSP underwent molecular screening of a large set of genes, using two different customized NGS panels. The latest version of our targeted sequencing panel (

Indexed as

diagnostic yieldhereditary spastic paraplegianeurogeneticsnext generation sequencingvariants of unknown significance

Identifiers

PMID30564185
PMCPMC6289125
OpenAlexW2902650947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.